Related Experiment Video
Updated: May 26, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization
Scott J Hebbring1, Yubo Chai, Yuan Ji
1Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
Genetic variations in serine hydroxymethyltransferase (SHMT1 and SHMT2) genes were analyzed. Some variants impact SHMT1 gene expression, suggesting co-regulation within folate and methionine pathways.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Serine hydroxymethyltransferase (SHMT) is crucial for neurotransmitter synthesis and metabolism.
- SHMT catalyzes the conversion of serine to glycine and 5,10-methylene-tetrahydrofolate.
Purpose of the Study:
- To resequence SHMT1 and SHMT2 genes and conduct functional genomic studies.
- To investigate the impact of genetic polymorphisms on SHMT gene function and expression.
Main Methods:
- Gene resequencing of SHMT1 and SHMT2.
- Identification and functional analysis of single-nucleotide polymorphisms (SNPs).
- Imputation of variants using '1000 Genomes' data and expression quantitative trait loci (eQTL) analysis.
- Reporter gene assays and correlation analysis with protein expression.
Main Results:
- Identified 87 polymorphisms in SHMT1 and 60 in SHMT2.
- No significant functional effect of 13 non-synonymous SNPs on catalytic activity or protein levels.
- 14 variants significantly associated with SHMT1 mRNA expression; several correlated with SHMT1 protein levels.
- SHMT1 promoter SNP rs669340 implicated in expression variation.
- SHMT1 and SHMT2 expression correlated with other Folate and Methionine Cycle genes.
Conclusions:
- Comprehensive analysis of SHMT1 and SHMT2 sequence variation and functional implications.
- Preliminary evidence suggests co-regulation of SHMT genes with Folate and Methionine Cycle genes.
More Related Videos
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

